Delivery Order SPE2DB20D3101-SPE2DB24FRBE2
Award Date
2/8/24
Potential Completion Date
2/9/24
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,549.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Prilosec DR 10 mg suspension, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,475.62 Delivery Order (SPE2DB23FRVD2) is for the supply of 30 suspension packages of the drug Prilosec 10 mg. The contract has a firm fixed price and an ultimate completion date of August 17, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $2,714.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Prilosec DR 10 mg suspension, a prescription medication, to support military healthcare programs. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award is for the delivery of Prilosec DR 10 mg suspension to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $2,498.94. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is May 3, 2024. The contract did not have a set-aside...
This federal contract award is for the delivery of Prilosec DR 10 mg suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $12,609.47 and an ultimate completion date of August 8, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support...
This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA). The $1,348.70 firm fixed price contract is for the provision of Prilosec DR 10 mg pharmaceutical suspension. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and is providing these pharmaceutical products from its corporate office in Conshohocken, Pennsylvania. This contract does not have a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at up to $3,316.27, is for the delivery of 4564339546 PRILOSEC DR 10 MG SUSPENSION 30S, a prescription medication. The contract is a Firm Fixed Price Delivery Order without a set-aside designation. Amerisourcebergen holds a much larger Indefinite...
This federal contract award is for the delivery of PRILOSEC DR 2.5 MG SUSPENSION 30S pharmaceutical products to the Defense Logistics Agency (DLA). The $3,510.88 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,559.32 firm fixed-price delivery order (SPE2DB22D3004|SPE2DB25FPS06) is for the supply of PRILOSEC DR 10 MG SUSPENSION 30S to support military healthcare programs. The contract has an ultimate completion date of February 27, 2025 and was awarded on February 26, 2025. It is not designated as a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,244.14, is a Firm Fixed Price Delivery Order for the supply of 4,567,089,178 units of Omeprazole DR 20 mg capsules. The contract is not designated under any set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...